Literature DB >> 25365749

Out-of-plan medication in Medicare Part D.

Pamela N Roberto1, Bruce Stuart.   

Abstract

OBJECTIVES: To determine the extent to which Medicare Part D enrollees fill unadjudicated prescriptions for diabetes, hypertension, and hyperlipidemia medications outside of the Part D benefit. STUDY
DESIGN: Retrospective analysis of prescriptions filled by community-dwelling beneficiaries continually enrolled in a Medicare Part D plan in 2009.
METHODS: We used the Medicare Current Beneficiary Survey to compare self-reported prescription fills for oral antidiabetes medications, renin-angiotensin-aldosterone system inhibitors, and statins to adjudicated prescription drug event data recorded by Part D plan sponsors. For unadjudicated prescriptions with no evidence of Part D payment, we determined whether the fills were paid for in cash, filled through VA pharmacies or discount generic programs, or had other reported sources of coverage.
RESULTS: A total of 6.2% of all prescriptions filled by Part D beneficiaries were unadjudicated, ranging from 5.3% of all oral antidiabetes medications to 6.8% of statins. Cash prescriptions accounted for more than half of all out-of-plan use, but we found little evidence of unadjudicated out-of-plan use of discount generics. Prescriptions filled at VA pharmacies and those with other reported sources of coverage each accounted for about 1% of total fills.
CONCLUSIONS: Out-of-plan medication use accounts for a small share of total prescriptions filled by Part D beneficiaries. Nevertheless, CMS should continue to work with plan sponsors to develop initiatives that facilitate the collection of beneficiaries' complete utilization data, as a more complete reporting could improve the quality of care delivered to Part D enrollees.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25365749

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  9 in total

1.  High health care costs in minority groups of older US Medicare beneficiaries with epilepsy.

Authors:  Maria Pisu; Joshua Richman; Jerzy P Szaflarski; Ellen Funkhouser; Chen Dai; Lucia Juarez; Edward Faught; Roy C Martin
Journal:  Epilepsia       Date:  2019-06-06       Impact factor: 5.864

2.  Assessing Medicare Part D claim completeness using medication self-reports: the role of veteran status and Generic Drug Discount Programs.

Authors:  Lei Zhou; Sally C Stearns; Emily M Thudium; Khalid A Alburikan; Jo E Rodgers
Journal:  Med Care       Date:  2015-05       Impact factor: 2.983

3.  A Comparison of Self-reported Medication Adherence to Concordance Between Part D Claims and Medication Possession.

Authors:  Samuel T Savitz; Sally C Stearns; Lei Zhou; Emily Thudium; Khalid A Alburikan; Richard Tran; Jo E Rodgers
Journal:  Med Care       Date:  2017-05       Impact factor: 2.983

4.  Quality of Antiepileptic Treatment Among Older Medicare Beneficiaries With Epilepsy: A Retrospective Claims Data Analysis.

Authors:  Maria Pisu; Joshua Richman; Kendra Piper; Roy Martin; Ellen Funkhouser; Chen Dai; Lucia Juarez; Jerzy P Szaflarski; Edward Faught
Journal:  Med Care       Date:  2017-07       Impact factor: 2.983

5.  Predictors of prevalent statin use among older adults identified as statin initiators based on Medicare claims data.

Authors:  Jessica C Young; Til Stürmer; Jennifer L Lund; Michele Jonsson Funk
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-03-15       Impact factor: 2.890

6.  Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.

Authors:  Gang Fang; Izabela E Annis; Joel F Farley; Nirosha Mahendraratnam; Ryan P Hickson; Til Stürmer; Jennifer G Robinson
Journal:  Pharmacotherapy       Date:  2017-12-11       Impact factor: 4.705

7.  Agreement between Medicare pharmacy claims, self-report, and medication inventory for assessing lipid-lowering medication use.

Authors:  Lisandro D Colantonio; Shia T Kent; Meredith L Kilgore; Elizabeth Delzell; Jeffrey R Curtis; George Howard; Monika M Safford; Paul Muntner
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-01-29       Impact factor: 2.890

8.  It's Not Too Late to Improve Statin Adherence: Association Between Changes in Statin Adherence from Before to After Acute Myocardial Infarction and All-Cause Mortality.

Authors:  Ryan P Hickson; Jennifer G Robinson; Izabela E Annis; Ley A Killeya-Jones; Gang Fang
Journal:  J Am Heart Assoc       Date:  2019-04-02       Impact factor: 5.501

9.  Changes in Statin Adherence Following an Acute Myocardial Infarction Among Older Adults: Patient Predictors and the Association With Follow-Up With Primary Care Providers and/or Cardiologists.

Authors:  Ryan P Hickson; Jennifer G Robinson; Izabela E Annis; Ley A Killeya-Jones; Maarit Jaana Korhonen; Ashley L Cole; Gang Fang
Journal:  J Am Heart Assoc       Date:  2017-10-19       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.